PRO-Kinetic: results from an "all-comers" single centre clinical experience.
To conduct a clinical registry of consecutive "real world" patients treated using the PRO-Kinetic stent at Rabin Medical Centre between January 2006 and March 2008. Our study included 515 consecutive patients treated for 540 lesions. We had a 100% follow-up rate at six months. The patients' characteristics are noted as having a 43% rate of diabetics and a 17% renal insufficiency. Indications for angioplasty included patients with either stable or unstable clinical scenarios and 60% of the lesions were of class B2/C. The mean RVD was 2.81 mm and lesions length was 12.6 mm prior to PCI and with angiographic success in 99.8% of treated lesions. The six month clinical outcome data were as follow: MACE rate of 8.7% with 3.5% total mortality, 1.9% cardiac mortality, 1.4% of any MI and TVR rate of 6.4% per treated patient and 6.7% per treated lesion and 0.4% rate of stent thrombosis. Based on our findings, 1) The PRO-Kinetic clinical data shows excellent results on a large group of coronary patients, treated consecutively. 2) The data should emphasise the remaining role of 'state of the art' non DES platforms (i.e. such as PRO-Kinetic) for patients with a wide variety of characteristics and/or clinical syndromes.